Literature DB >> 19539998

Subgenual cingulate and visual cortex responses to sad faces predict clinical outcome during antidepressant treatment for depression.

Paul A Keedwell1, Dominique Drapier, Simon Surguladze, Vincent Giampietro, Mick Brammer, Mary Phillips.   

Abstract

BACKGROUND: Previous follow-up studies indicate that increased visual cortical, ventral cingulate and subcortical responses of depressed individuals to sad facial stimuli, but not happy stimuli could represent reversible markers of disease severity. We hypothesized that greater responses in these areas to sad stimuli, but not happy stimuli, would predict better subsequent clinical outcome. We also explored areas that would predict a poor outcome.
METHODS: Twelve melancholically depressed individuals in the early stages of antidepressant treatment in a secondary care setting participated in two experiments comparing responses to varying intensities of sad and happy facial stimuli, respectively, using event related functional MRI. They repeated the experiments after a mean delay of 12 weeks of treatment.
RESULTS: There was a variation in response to treatment. Greater right visual cortex and right subgenual cingulate (R-BA25) responses to sad stimuli, but not happy stimuli, in the early stages of treatment were associated with a good clinical outcome. Greater ventrolateral prefrontal cortex responses to either stimulus type were associated with a relatively poor outcome. LIMITATIONS: The sample size was modest and patients were taking a variety of antidepressants.
CONCLUSIONS: Right subgenual cingulate and right visual cortical responses to sad stimuli predict good clinical outcome in the context of antidepressant treatment for severe depression in a naturalistic setting. Ventrolateral prefrontal cortex activity may indicate poor prognosis due to its relationship with negative rumination.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19539998     DOI: 10.1016/j.jad.2009.04.031

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  39 in total

Review 1.  Frontocingulate dysfunction in depression: toward biomarkers of treatment response.

Authors:  Diego A Pizzagalli
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

2.  Functional brain activation to emotionally valenced faces in school-aged children with a history of preschool-onset major depression.

Authors:  Deanna M Barch; Michael S Gaffrey; Kelly N Botteron; Andrew C Belden; Joan L Luby
Journal:  Biol Psychiatry       Date:  2012-07-07       Impact factor: 13.382

3.  Variation in the corticotropin-releasing hormone receptor 1 (CRHR1) gene influences fMRI signal responses during emotional stimulus processing.

Authors:  David T Hsu; Brian J Mickey; Scott A Langenecker; Mary M Heitzeg; Tiffany M Love; Heng Wang; Susan E Kennedy; Marta Peciña; Tal Shafir; Colin A Hodgkinson; Mary-Anne Enoch; David Goldman; Jon-Kar Zubieta
Journal:  J Neurosci       Date:  2012-02-29       Impact factor: 6.167

4.  fMRI response to negative words and SSRI treatment outcome in major depressive disorder: a preliminary study.

Authors:  Jeffrey Morris Miller; Noam Schneck; Greg J Siegle; Yakuan Chen; R Todd Ogden; Toshiaki Kikuchi; Maria A Oquendo; J John Mann; Ramin V Parsey
Journal:  Psychiatry Res       Date:  2013-12-30       Impact factor: 3.222

5.  fMRI BOLD responses to negative stimuli in the prefrontal cortex are dependent on levels of recent negative life stress in major depressive disorder.

Authors:  David T Hsu; Scott A Langenecker; Susan E Kennedy; Jon-Kar Zubieta; Mary M Heitzeg
Journal:  Psychiatry Res       Date:  2010-08-03       Impact factor: 3.222

6.  The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocols

Authors:  Glenda M. MacQueen; Stefanie Hassel; Stephen R. Arnott; Addington Jean; Christopher R. Bowie; Signe L. Bray; Andrew D. Davis; Jonathan Downar; Jane A. Foster; Benicio N. Frey; Benjamin I. Goldstein; Geoffrey B. Hall; Kate L. Harkness; Jacqueline Harris; Raymond W. Lam; Catherine Lebel; Roumen Milev; Daniel J. Müller; Sagar V. Parikh; Sakina Rizvi; Susan Rotzinger; Gulshan B. Sharma; Claudio N. Soares; Gustavo Turecki; Fidel Vila-Rodriguez; Joanna Yu; Mojdeh Zamyadi; Stephen C. Strother; Sidney H. Kennedy
Journal:  J Psychiatry Neurosci       Date:  2019-07-01       Impact factor: 6.186

7.  Differentiating neural systems mediating the acquisition vs. expression of goal-directed and habitual behavioral control.

Authors:  Mimi Liljeholm; Simon Dunne; John P O'Doherty
Journal:  Eur J Neurosci       Date:  2015-04-18       Impact factor: 3.386

8.  How cognitive performance-induced stress can influence right VLPFC activation: an fMRI study in healthy subjects and in patients with social phobia.

Authors:  Lejla Koric; Emmanuelle Volle; Magali Seassau; Frédéric A Bernard; Julien Mancini; Bruno Dubois; Antoine Pelissolo; Richard Levy
Journal:  Hum Brain Mapp       Date:  2011-07-18       Impact factor: 5.038

9.  Decreased occipital cortical glutamate levels in response to successful cognitive-behavioral therapy and pharmacotherapy for major depressive disorder.

Authors:  Chadi G Abdallah; Mark J Niciu; Lisa R Fenton; Madonna K Fasula; Lihong Jiang; Anne Black; Douglas L Rothman; Graeme F Mason; Gerard Sanacora
Journal:  Psychother Psychosom       Date:  2014-08-06       Impact factor: 17.659

10.  An fMRI study of emotional face processing in adolescent major depression.

Authors:  Leah M J Hall; Bonnie Klimes-Dougan; Ruskin H Hunt; Kathleen M Thomas; Alaa Houri; Emily Noack; Bryon A Mueller; Kelvin O Lim; Kathryn R Cullen
Journal:  J Affect Disord       Date:  2014-07-02       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.